HUTCHMED (China) Limited
HUTCHMED (China) Limited (HCM) Revenue
Annual & quarterly revenue history · segment & region breakdown
HCM · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsHUTCHMED (China) Limited trailing twelve-month (TTM) revenue is $0.60B, a decrease of 12.73% year-over-year from $0.55B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.55B | -$0.08B | -12.73% |
| 2024-12-31 | $0.63B | -$0.21B | -24.80% |
| 2023-12-31 | $0.84B | +$0.41B | +96.52% |
| 2022-12-31 | $0.43B | +$0.07B | +19.73% |
| 2021-12-31 | $0.36B | +$0.13B | +56.21% |
| 2020-12-31 | $0.23B | +$0.02B | +11.27% |
| 2019-12-31 | $0.20B | -$0.01B | -4.31% |
| 2018-12-31 | $0.21B | -$0.03B | -11.23% |
| 2017-12-31 | $0.24B | +$0.03B | +11.63% |
| 2016-12-31 | $0.22B | +$0.04B | +21.25% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare HCM revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income HUTCHMED (China) Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
HUTCHMED (China) Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from HUTCHMED (China) Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HCM revenue · 5 questionsHCM's trailing twelve-month (TTM) revenue is $0.60B. That is a decrease of 12.73% year-over-year from $0.55B in FY2025.
▸ Source: FMP · HUTCHMED (China) Limited SEC filings · GAAP · HUTCHMED (China) Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026